Pharmaceutical News and Articles

Some CDC Lab Testing Paused Amid Internal Review

FRIDAY, April 3, 2026 The U.S. Centers for Disease Control and Prevention (CDC) has paused more than two dozen types of lab tests. Officials said the move is te

Therapists' Well-Being Tied to Client Dropout Rates

Mental health clients are less likely to drop out of therapy early when their therapists self-report they are flourishing (doing well across life and work), acc

Odds of Advanced Liver Fibrosis Up With Episodic Heavy Drinking

Episodic heavy drinking is prevalent in metabolic dysfunction-associated steatotic liver disease (MASLD) and is associated with significantly higher odds of adv

Peeled Garlic Recalled Over Risk of Deadly Botulism

FRIDAY, April 3, 2026 Some peeled garlic is being recalled because it may pose a risk for a serious type of food poisoning. Tops Friendly Markets announced the

New Heart Diet Advice Counters U.S. Guidance on Meat and Dairy

FRIDAY, April 3, 2026 The nation s leading heart health organization is urging people to rethink where they get their protein. The goal Focus more on plants. Th

USDA Warns of Lead Risk in Frozen Dino-Shaped Chicken Nuggets

FRIDAY, April 3, 2026 Food safety officials are warning the public not to eat certain frozen chicken nuggets after tests found dangerous levels of lead. The U.S

Fluvoxamine Improves Fatigue, QoL in Long COVID

For patients with postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), fluvoxamine seems effective for reducing fatigue and impro

Addition of Atezolizumab to mFOLFOX6 Ups DFS in Stage III dMMR Colon Cancer

For patients with stage III mismatch repair-deficient (dMMR) colon cancer, the addition of the anti-programmed death ligand 1 agent atezolizumab to a modified r

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

FORE Biotherapeutics Receives Breakthrough Therapy Designation for Plixorafenib

PHILADELPHIA (BUSINESS WIRE) April 1, 2026 FORE Biotherapeutics, a registration stage company dedicated to developing targeted therapies to treat patients with